| FYN |
FYN: Proto-oncogene tyrosine-protein kinase Fyn |
GHR |
GHR: Growth hormone receptor precursor |
24.950 |
Evidence |
|
| FYN |
FYN: Proto-oncogene tyrosine-protein kinase Fyn |
CD3E |
CD3E, T3E: T-cell surface glycoprotein CD3 epsilon chain precursor |
24.950 |
Evidence |
|
| CD5 |
CD5, LEU1: T-cell surface glycoprotein CD5 precursor |
FYN |
FYN: Proto-oncogene tyrosine-protein kinase Fyn |
24.950 |
Evidence |
|
| CD1A |
CD1A: T-cell surface glycoprotein CD1a precursor |
FYN |
FYN: Proto-oncogene tyrosine-protein kinase Fyn |
24.950 |
Evidence |
|
| FGB |
FGB: Fibrinogen beta chain precursor [Contains: Fibrinopeptide B] |
FGFR3 |
FGFR3, JTK4: Fibroblast growth factor receptor 3 precursor |
24.950 |
Evidence |
|
| FOS |
FOS, G0S7: Proto-oncogene protein c-fos |
MAPK10 |
MAPK10, JNK3, JNK3A, PRKM10: Mitogen-activated protein kinase 10 |
24.950 |
Evidence |
|
| FOS |
FOS, G0S7: Proto-oncogene protein c-fos |
MAPK8 |
MAPK8, JNK1, PRKM8: Mitogen-activated protein kinase 8 |
24.950 |
Evidence |
|
| JAK2 |
JAK2: Tyrosine-protein kinase JAK2 |
PTPRC |
PTPRC, RP11-553K8.4-001, hCG_1811178: Protein tyrosine phosphatase, receptor typ |
24.950 |
Evidence |
|
| JAK2 |
JAK2: Tyrosine-protein kinase JAK2 |
PTPRE |
PTPRE: Receptor-type tyrosine-protein phosphatase epsilon precursor |
24.950 |
Evidence |
|
| JAK2 |
JAK2: Tyrosine-protein kinase JAK2 |
TRPV4 |
TRPV4, VRL2, VROAC: Transient receptor potential cation channel subfamily V memb |
24.950 |
Evidence |
|
| JAK2 |
JAK2: Tyrosine-protein kinase JAK2 |
ADAM15 |
ADAM15, MDC15: ADAM 15 precursor |
24.950 |
Evidence |
|
| JAK2 |
JAK2: Tyrosine-protein kinase JAK2 |
CD79B |
CD79B, B29, IGB: B-cell antigen receptor complex-associated protein beta-chain p |
24.950 |
Evidence |
|
| JAK2 |
JAK2: Tyrosine-protein kinase JAK2 |
CD247 |
CD247, CD3Z, T3Z, TCRZ: T-cell surface glycoprotein CD3 zeta chain precursor |
24.950 |
Evidence |
|
| NCK2 |
NCK2: Cytoplasmic protein NCK2 |
MDGA1 |
MDGA1, MAMDC3: MAM domain-containing glycosylphosphatidylinositol anchor protein |
24.950 |
Evidence |
|
| LAT |
LAT: Linker for activation of T-cells family member 1 |
FYN |
FYN: Proto-oncogene tyrosine-protein kinase Fyn |
24.950 |
Evidence |
|
| SOCS3 |
SOCS3, CIS3, SSI3: Suppressor of cytokine signaling 3 |
STAT1 |
STAT1: Signal transducer and activator of transcription 1-alpha/beta |
24.950 |
Evidence |
|
| TRPC4 |
TRPC4: Short transient receptor potential channel 4 |
TRPC5 |
TRPC5, TRP5: Short transient receptor potential channel 5 |
24.920 |
Evidence |
|
| KCNJ6 |
KCNJ6, GIRK2, KATP2, KCNJ7: G protein-activated inward rectifier potassium chann |
KCNJ2 |
KCNJ2, HIRK1: Inward rectifier potassium channel 2 |
24.920 |
Evidence |
|
| MYF5 |
MYF5: Myogenic factor 5 |
NHLH2 |
NHLH2, HEN2: Helix-loop-helix protein 2 |
24.920 |
Evidence |
|
| SOCS1 |
SOCS1, SSI1, TIP3: Suppressor of cytokine signaling 1 |
TYK2 |
TYK2: Non-receptor tyrosine-protein kinase TYK2 |
24.920 |
Evidence |
|
| IQGAP1 |
IQGAP1, KIAA0051: Ras GTPase-activating-like protein IQGAP1 |
RRAD |
RRAD, RAD: GTP-binding protein RAD |
24.880 |
Evidence |
|
| STAT5A |
STAT5A, STAT5: Signal transducer and activator of transcription 5A |
IRS4 |
IRS4, RP6-24A23.4-001, hCG_20762: Insulin receptor substrate 4 |
24.880 |
Evidence |
|
| IRS1 |
IRS1: Insulin receptor substrate 1 |
STAT5B |
STAT5B: Signal transducer and activator of transcription 5B |
24.880 |
Evidence |
|
| FLT1 |
FLT1, FLT, FRT: Vascular endothelial growth factor receptor 1 precursor |
MAG |
MAG, GMA: Myelin-associated glycoprotein precursor |
24.880 |
Evidence |
|
| PDGFRA |
PDGFRA: Alpha-type platelet-derived growth factor receptor precursor |
ERBB4 |
ERBB4, HER4: Receptor tyrosine-protein kinase erbB-4 precursor |
24.880 |
Evidence |
|